HRP20020911B1 - Substituted pyrrolopyridinone derivatives useful as phosphodiesterase inhibitors - Google Patents
Substituted pyrrolopyridinone derivatives useful as phosphodiesterase inhibitorsInfo
- Publication number
- HRP20020911B1 HRP20020911B1 HR20020911A HRP20020911A HRP20020911B1 HR P20020911 B1 HRP20020911 B1 HR P20020911B1 HR 20020911 A HR20020911 A HR 20020911A HR P20020911 A HRP20020911 A HR P20020911A HR P20020911 B1 HRP20020911 B1 HR P20020911B1
- Authority
- HR
- Croatia
- Prior art keywords
- c6alkyl
- independently selected
- group
- nhra
- substituents independently
- Prior art date
Links
- 229940082638 cardiac stimulant phosphodiesterase inhibitors Drugs 0.000 title 1
- 239000002571 phosphodiesterase inhibitor Substances 0.000 title 1
- ORKUYZDMEWAUEZ-UHFFFAOYSA-N pyrrolo[3,2-b]pyridin-2-one Chemical class N1=CC=CC2=NC(=O)C=C21 ORKUYZDMEWAUEZ-UHFFFAOYSA-N 0.000 title 1
- 125000001424 substituent group Chemical group 0.000 abstract 9
- -1 amino, acetyl Chemical group 0.000 abstract 7
- 229910052736 halogen Inorganic materials 0.000 abstract 6
- 150000002367 halogens Chemical group 0.000 abstract 6
- 125000001072 heteroaryl group Chemical group 0.000 abstract 5
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 abstract 4
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 abstract 4
- 125000003710 aryl alkyl group Chemical group 0.000 abstract 3
- 125000003118 aryl group Chemical group 0.000 abstract 3
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 abstract 3
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 3
- 125000004916 (C1-C6) alkylcarbonyl group Chemical group 0.000 abstract 2
- 125000004739 (C1-C6) alkylsulfonyl group Chemical group 0.000 abstract 2
- MDFFNEOEWAXZRQ-UHFFFAOYSA-N aminyl Chemical compound [NH2] MDFFNEOEWAXZRQ-UHFFFAOYSA-N 0.000 abstract 2
- 125000004093 cyano group Chemical group *C#N 0.000 abstract 2
- 125000000592 heterocycloalkyl group Chemical group 0.000 abstract 2
- 229910052739 hydrogen Inorganic materials 0.000 abstract 2
- 239000001257 hydrogen Substances 0.000 abstract 2
- 125000004435 hydrogen atom Chemical class [H]* 0.000 abstract 2
- 125000004043 oxo group Chemical group O=* 0.000 abstract 2
- 125000000876 trifluoromethoxy group Chemical group FC(F)(F)O* 0.000 abstract 2
- 125000004178 (C1-C4) alkyl group Chemical group 0.000 abstract 1
- 125000000229 (C1-C4)alkoxy group Chemical group 0.000 abstract 1
- 125000004454 (C1-C6) alkoxycarbonyl group Chemical group 0.000 abstract 1
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 abstract 1
- 125000000738 acetamido group Chemical group [H]C([H])([H])C(=O)N([H])[*] 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 125000000753 cycloalkyl group Chemical group 0.000 abstract 1
- 125000005842 heteroatom Chemical group 0.000 abstract 1
- 125000001624 naphthyl group Chemical group 0.000 abstract 1
- 125000003170 phenylsulfonyl group Chemical group C1(=CC=CC=C1)S(=O)(=O)* 0.000 abstract 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/06—Antiabortive agents; Labour repressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Gynecology & Obstetrics (AREA)
- Diabetes (AREA)
- Pulmonology (AREA)
- Hematology (AREA)
- Pregnancy & Childbirth (AREA)
- Vascular Medicine (AREA)
- Hospice & Palliative Care (AREA)
- Obesity (AREA)
- Emergency Medicine (AREA)
- Urology & Nephrology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US20464600P | 2000-05-17 | 2000-05-17 | |
PCT/US2001/014391 WO2001087882A2 (fr) | 2000-05-17 | 2001-05-03 | Derives de pyrrolopyridinone substitues utiles en tant qu'inhibiteurs de la phosphodiesterase |
Publications (2)
Publication Number | Publication Date |
---|---|
HRP20020911A2 HRP20020911A2 (en) | 2004-12-31 |
HRP20020911B1 true HRP20020911B1 (en) | 2009-01-31 |
Family
ID=22758822
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HR20020911A HRP20020911B1 (en) | 2000-05-17 | 2002-11-15 | Substituted pyrrolopyridinone derivatives useful as phosphodiesterase inhibitors |
Country Status (29)
Country | Link |
---|---|
US (3) | US6635638B2 (fr) |
EP (1) | EP1296981B1 (fr) |
JP (1) | JP5366349B2 (fr) |
KR (2) | KR20030031483A (fr) |
CN (1) | CN1280291C (fr) |
AR (1) | AR028575A1 (fr) |
AT (1) | ATE278690T1 (fr) |
AU (1) | AU6117801A (fr) |
BG (1) | BG65925B1 (fr) |
CA (1) | CA2409743C (fr) |
CZ (1) | CZ20023945A3 (fr) |
DE (1) | DE60106252T2 (fr) |
ES (1) | ES2230316T3 (fr) |
GE (1) | GEP20053510B (fr) |
HK (1) | HK1054034B (fr) |
HR (1) | HRP20020911B1 (fr) |
HU (1) | HUP0302226A3 (fr) |
IL (2) | IL152872A0 (fr) |
MX (1) | MXPA02011425A (fr) |
MY (1) | MY126917A (fr) |
NO (1) | NO324843B1 (fr) |
NZ (1) | NZ522732A (fr) |
PL (1) | PL363150A1 (fr) |
PT (1) | PT1296981E (fr) |
RU (1) | RU2267490C2 (fr) |
SK (1) | SK286992B6 (fr) |
UA (1) | UA72611C2 (fr) |
WO (1) | WO2001087882A2 (fr) |
ZA (1) | ZA200210114B (fr) |
Families Citing this family (33)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
UA72611C2 (uk) * | 2000-05-17 | 2005-03-15 | Орто-Макнейл Фармацевтикал, Інк. | Похідні заміщеного піролопіридинону, корисні як інгібітори фосфодіестерази |
EP1360186B1 (fr) | 2001-02-12 | 2006-11-22 | Lilly Icos LLC | Composes chimiques |
ATE302775T1 (de) | 2001-02-12 | 2005-09-15 | Lilly Icos Llc | Carbolinderivate |
CN1280292C (zh) | 2001-11-14 | 2006-10-18 | 奥索-麦克尼尔药品公司 | 用作磷酸二酯酶抑制剂的被取代的四环吡咯并喹诺酮衍生物 |
JP4916662B2 (ja) * | 2002-06-19 | 2012-04-18 | ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ | ホスホジエステラーゼ阻害剤として有用な置換2,4−ジヒドロ−ピロロ(3,4−b)−キノリン−9−オン誘導体 |
US7045652B2 (en) * | 2002-07-03 | 2006-05-16 | Pfizer Inc | Processes for preparing substituted aryl boronic acids |
US8076353B2 (en) | 2004-03-15 | 2011-12-13 | Ptc Therapeutics, Inc. | Inhibition of VEGF translation |
US8076352B2 (en) | 2004-03-15 | 2011-12-13 | Ptc Therapeutics, Inc. | Administration of carboline derivatives useful in the treatment of cancer and other diseases |
EA016575B1 (ru) | 2004-03-15 | 2012-06-29 | ПиТиСи ТЕРАПЬЮТИКС, ИНК. | Производные карболина, полезные в ингибировании ангиогенеза |
US7767689B2 (en) | 2004-03-15 | 2010-08-03 | Ptc Therapeutics, Inc. | Carboline derivatives useful in the treatment of cancer |
EP1851227A4 (fr) * | 2005-02-25 | 2010-03-10 | Janssen Pharmaceutica Nv | Procede efficace et stereoselectif de synthese a grande echelle de 3-(r)-3- (2,3-dihydrobenzofuran-5-yl)-1,2,3,4- tetrahydropyrrolo{3,4-b}quinolin-9-ones |
WO2006093719A1 (fr) * | 2005-02-25 | 2006-09-08 | Janssen Pharmaceutica, N.V. | Procede efficace et stereoselectif de synthese a grande echelle de 3-(r)-3- (2,3-dihydrobenzofuran-5-yl)-1,2,3,4- tetrahydropyrrolo{3,4-b}quinolin-9-ones |
EP2258358A3 (fr) | 2005-08-26 | 2011-09-07 | Braincells, Inc. | Neurogenèse avec un inhibiteur de l'acetylcholinestérase |
WO2007025177A2 (fr) | 2005-08-26 | 2007-03-01 | Braincells, Inc. | Neurogenese par modulation du recepteur muscarinique |
EP2377530A3 (fr) | 2005-10-21 | 2012-06-20 | Braincells, Inc. | Modulation de neurogénèse par inhibition PDE |
US20070112017A1 (en) | 2005-10-31 | 2007-05-17 | Braincells, Inc. | Gaba receptor mediated modulation of neurogenesis |
US20100216734A1 (en) | 2006-03-08 | 2010-08-26 | Braincells, Inc. | Modulation of neurogenesis by nootropic agents |
EP2377531A2 (fr) | 2006-05-09 | 2011-10-19 | Braincells, Inc. | Neurogénèse par modulation de l'angiotensine |
US7678808B2 (en) | 2006-05-09 | 2010-03-16 | Braincells, Inc. | 5 HT receptor mediated neurogenesis |
MX2009002496A (es) | 2006-09-08 | 2009-07-10 | Braincells Inc | Combinaciones que contienen un derivado de 4-acilaminopiridina. |
US20100184806A1 (en) | 2006-09-19 | 2010-07-22 | Braincells, Inc. | Modulation of neurogenesis by ppar agents |
JP2012513464A (ja) | 2008-12-23 | 2012-06-14 | ザ トラスティーズ オブ コロンビア ユニヴァーシティ イン ザ シティ オブ ニューヨーク | ホスホジエステラーゼ阻害剤及びその使用 |
WO2010099217A1 (fr) | 2009-02-25 | 2010-09-02 | Braincells, Inc. | Modulation de neurogenèse à l'aide de combinaisons de d-cyclosérine |
RU2451686C1 (ru) * | 2010-12-27 | 2012-05-27 | Александр Васильевич Иващенко | ЗАМЕЩЕННЫЕ ГИДРИРОВАННЫЕ ТИЕНО-ПИРРОЛО [3,2-c] ПИРИДИНЫ, ЛИГАНДЫ, ФАРМАЦЕВТИЧЕСКАЯ КОМПОЗИЦИЯ И СПОСОБ ИХ ПРИМЕНЕНИЯ |
KR101236188B1 (ko) * | 2011-03-10 | 2013-02-22 | 한국화학연구원 | 신규한 피롤로피리디논 유도체 및 그의 mch 수용체-1 관련 질환에 대한 치료학적 용도 |
EP2757887B1 (fr) | 2011-09-22 | 2017-04-26 | VIIV Healthcare UK Limited | Composés pyrrolopyridinones et méthodes de traitement du vih |
EP2804603A1 (fr) | 2012-01-10 | 2014-11-26 | President and Fellows of Harvard College | Composés promoteurs de réplication des cellules bêta et leurs procédés d'utilisation |
JO3407B1 (ar) | 2012-05-31 | 2019-10-20 | Eisai R&D Man Co Ltd | مركبات رباعي هيدرو بيرازولو بيريميدين |
US11427600B2 (en) | 2014-06-27 | 2022-08-30 | Nogra Pharma Limited | Aryl receptor modulators and methods of making and using the same |
WO2017168174A1 (fr) | 2016-04-02 | 2017-10-05 | N4 Pharma Uk Limited | Nouvelles formes pharmaceutiques du sildénafil |
CN107216327A (zh) * | 2017-06-27 | 2017-09-29 | 山东大学 | 5型磷酸二酯酶抑制剂及其制备方法和用途 |
CN108752340B (zh) * | 2018-07-18 | 2020-09-01 | 山东中医药大学附属医院 | 吡咯并喹啉衍生物及其在治疗心律失常中的用途 |
CN109134463B (zh) * | 2018-09-17 | 2020-05-08 | 山东大学 | β-咔啉类5型磷酸二酯酶抑制剂及其制备方法和用途 |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6043252A (en) * | 1997-05-05 | 2000-03-28 | Icos Corporation | Carboline derivatives |
Family Cites Families (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US204646A (en) * | 1878-06-04 | Improvement in hat-brims | ||
DE2023514A1 (de) | 1970-05-14 | 1971-12-02 | Badische Anilin- & Soda-Fabrik Ag, 6700 Ludwigshafen | Verfahren zur Herstellung von 5,6-gamma-Pyridonderivaten |
CH625521A5 (fr) | 1976-10-15 | 1981-09-30 | Sandoz Ag | |
US5126352A (en) | 1985-06-13 | 1992-06-30 | Schering Corporation | Polycyclic quinoline, naphthyridine and pyrazinopyridine derivatives |
US5250534A (en) * | 1990-06-20 | 1993-10-05 | Pfizer Inc. | Pyrazolopyrimidinone antianginal agents |
US5190951A (en) | 1990-10-19 | 1993-03-02 | Ss Pharmaceutical Co., Ltd. | Quinoline derivatives |
GB9311920D0 (en) * | 1993-06-09 | 1993-07-28 | Pfizer Ltd | Therapeutic agents |
GB9401090D0 (en) * | 1994-01-21 | 1994-03-16 | Glaxo Lab Sa | Chemical compounds |
ATE224377T1 (de) | 1994-04-29 | 2002-10-15 | Takeda Chemical Industries Ltd | Kondensierte heterocyclische verbindung, deren herstellung und verwendung als gnrh antagonisten |
DE4436509A1 (de) * | 1994-10-13 | 1996-04-18 | Hoechst Schering Agrevo Gmbh | Substituierte Spiroalkylamino- und alkoxy-Heterocyclen, Verfahren zu ihrer Herstellung und ihre Verwendung als Schädlingsbekämpfungsmittel und Fungizide |
CN1072219C (zh) | 1995-06-01 | 2001-10-03 | 武田药品工业株式会社 | 二氮杂䓬酮、其生产和用途 |
GB9514464D0 (en) * | 1995-07-14 | 1995-09-13 | Glaxo Lab Sa | Medicaments |
US6248739B1 (en) | 1999-01-08 | 2001-06-19 | Pharmacia & Upjohn Company | Quinolinecarboxamides as antiviral agents |
FR2792937B1 (fr) * | 1999-04-27 | 2001-08-10 | Cemaf | NOUVEAUX DERIVES DE PYRROLO-(3,4-b) QUINOLEINE, LEUR PROCEDE DE PREPARATION ET LEUR UTILISATION A TITRE DE MEDICAMENT |
UA72611C2 (uk) | 2000-05-17 | 2005-03-15 | Орто-Макнейл Фармацевтикал, Інк. | Похідні заміщеного піролопіридинону, корисні як інгібітори фосфодіестерази |
-
2001
- 2001-03-05 UA UA2002119180A patent/UA72611C2/uk unknown
- 2001-05-02 US US09/847,749 patent/US6635638B2/en not_active Expired - Lifetime
- 2001-05-03 AU AU6117801A patent/AU6117801A/xx not_active Withdrawn
- 2001-05-03 PT PT01935050T patent/PT1296981E/pt unknown
- 2001-05-03 MX MXPA02011425A patent/MXPA02011425A/es active IP Right Grant
- 2001-05-03 EP EP01935050A patent/EP1296981B1/fr not_active Expired - Lifetime
- 2001-05-03 SK SK1713-2002A patent/SK286992B6/sk not_active IP Right Cessation
- 2001-05-03 PL PL01363150A patent/PL363150A1/xx not_active IP Right Cessation
- 2001-05-03 CZ CZ20023945A patent/CZ20023945A3/cs unknown
- 2001-05-03 CN CNB018128440A patent/CN1280291C/zh not_active Expired - Fee Related
- 2001-05-03 JP JP2001584276A patent/JP5366349B2/ja not_active Expired - Fee Related
- 2001-05-03 WO PCT/US2001/014391 patent/WO2001087882A2/fr active Application Filing
- 2001-05-03 GE GE5004A patent/GEP20053510B/en unknown
- 2001-05-03 IL IL15287201A patent/IL152872A0/xx unknown
- 2001-05-03 DE DE60106252T patent/DE60106252T2/de not_active Expired - Lifetime
- 2001-05-03 CA CA2409743A patent/CA2409743C/fr not_active Expired - Fee Related
- 2001-05-03 KR KR1020027015582A patent/KR20030031483A/ko not_active Application Discontinuation
- 2001-05-03 RU RU2002133863/04A patent/RU2267490C2/ru not_active IP Right Cessation
- 2001-05-03 NZ NZ522732A patent/NZ522732A/en not_active IP Right Cessation
- 2001-05-03 KR KR1020027015580A patent/KR100854050B1/ko not_active IP Right Cessation
- 2001-05-03 AT AT01935050T patent/ATE278690T1/de active
- 2001-05-03 ES ES01935050T patent/ES2230316T3/es not_active Expired - Lifetime
- 2001-05-03 HU HU0302226A patent/HUP0302226A3/hu unknown
- 2001-05-16 AR ARP010102325A patent/AR028575A1/es active IP Right Grant
- 2001-05-16 MY MYPI20012295 patent/MY126917A/en unknown
-
2002
- 2002-11-15 IL IL152872A patent/IL152872A/en not_active IP Right Cessation
- 2002-11-15 HR HR20020911A patent/HRP20020911B1/xx not_active IP Right Cessation
- 2002-11-18 NO NO20025525A patent/NO324843B1/no not_active IP Right Cessation
- 2002-11-18 BG BG107284A patent/BG65925B1/bg unknown
- 2002-12-12 ZA ZA200210114A patent/ZA200210114B/en unknown
-
2003
- 2003-08-11 US US10/638,901 patent/US6818646B2/en not_active Expired - Lifetime
- 2003-09-08 HK HK03106376.8A patent/HK1054034B/zh not_active IP Right Cessation
-
2004
- 2004-10-22 US US10/971,476 patent/US20050113402A1/en not_active Abandoned
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6043252A (en) * | 1997-05-05 | 2000-03-28 | Icos Corporation | Carboline derivatives |
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HRP20020911B1 (en) | Substituted pyrrolopyridinone derivatives useful as phosphodiesterase inhibitors | |
HRP20090334T1 (en) | 3-[4-heterocyclyl-1,2,3-triazol-1-yl]-n-aryl-benzamides as inhibitors of the cytokines production for the treatment of chronic inflammatory diseases | |
RS51365B (en) | N-`(1-5-DIFENIL-1H-PIRAZOL-3-IL) DERIVATIVES SULFONAMIDE SA AFINITETOM ZA RECEPTOR CB1 | |
RS52210B (en) | CYCLOPENT [D] PYRIMIDINS AS PROTEIN KINASE ACTION INHIBITORS | |
RS52099B (en) | SUBSTITUTED BENZIMIDAZOLES AS KINASE INHIBITORS | |
TW200602056A (en) | Substituted 2-quinolyl-oxazoles useful as PDE4 inhibitors | |
EA200601007A1 (ru) | 7-фенилалкилзамещённые 2-хинолиноны и 2-хиноксалиноны в качестве ингибиторов поли(адф-рибоза)полимеразы | |
BR0213140A (pt) | Fungicidas de pirazol-pirimidina | |
EA200601125A1 (ru) | 6-замещённые циклогексилалкил 2-замещённые хинолиноны и 2-хиноксалиноны в качестве ингибиторов поли(adp-рибоза)полимеразы | |
ES2259113T3 (es) | Inhibidores del factor xa y de otras serinproteasas implicadas en la cascada de coagulacion. | |
RS50737B (sr) | Beta-amino tetrahidroimidazo (1,2-a)pirazini i tetrahidrotriazolo(4,3-a)pirazini kao inhibitori dipeptidil peptidaze u lečenju ili prevenciji dijabetesa | |
RS51097B (sr) | Glukokortikoidni mimetici,postupci za njihovo dobijanje, farmaceutski preparati i njihova primena | |
EA200700188A1 (ru) | Производные замещенного 2-алкилхиназолинона как ингибиторы parp | |
AR069326A1 (es) | Derivados bis-(sulfonilamino), proceso de preparacion, composiciones farmaceuticas que los contienen y su uso en terapia. | |
EA200700192A1 (ru) | Производные фталазина в качестве ингибиторов parp | |
EA200400987A1 (ru) | Трипептиды, несущие простой гидроксипролиновый эфир замещённого хинолина, предназначенные для ингибирования протеазы ns3 (гепатит c) | |
EA200601002A1 (ru) | 6-алкенил и 6-фенилалкил замещённые 2-хинолиноны и 2-хиноксалиноны в качестве ингибиторов поли(адф-рибоза) полимеразы | |
EA200601100A1 (ru) | 6-замещённые 2-хинолиноны и 2-хиноксалиноны как ингибиторы поли(адф-рибоза)полимеразы | |
RS54506B1 (en) | PICOLINAMIDE DERIVATIVES AS KINASE INHIBITORS | |
RS53629B1 (en) | CYAN ANTHRANYLAMIDE INSECTICIDES | |
ATE389638T1 (de) | Aminobenzamidderivate als inhibitoren der glycogensynthasekinase-3- | |
AR056764A1 (es) | Aminopirimidinas utiles como inhibidores de quinasa | |
RS50823B (sr) | Supstituisani 1h-pirolo[3,2-b, 3,2-c, i 2,3-c]piridin-2-karboksamidi i srodni analozi kao inhibitori kazein kinaze i epsilon | |
RS52723B (en) | NEW PIRAZOL-4-N-ALCOXYCARBOXAMIDES AS MICROBIOCIDES | |
HRP20090078A2 (en) | Novel pyridazine compound and use thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A1OB | Publication of a patent application | ||
ARAI | Request for the grant of a patent on the basis of the submitted results of a substantive examination of a patent application | ||
B1PR | Patent granted | ||
ODRP | Renewal fee for the maintenance of a patent |
Payment date: 20140410 Year of fee payment: 14 |
|
PBON | Lapse due to non-payment of renewal fee |
Effective date: 20150503 |